首页> Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists> Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy

Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy

导出原文传递

翻译打印收藏纠错

第一作者： Cross, Kristina M.

作者： Cross, Kristina M. ^[1] ; Landis, Dylan M. ^[2] ; Sehgal, Laveena ; Payne, J. Drew

作者单位： Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA ^[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, 3601 4th St Stop 9410, Lubbock, TX 79430 USA ^[2]

关键词 melatonin COVID-19 viral diseases SARS-CoV-2 antioxidant anti-inflammatory agent

发布时间 2021-12-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Endocrine practice

2021年27卷8期

850-855页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Endocrine practice

2021年27卷8期

850-855页

检索历史清除

Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy

Endocrine practice

相似文献

同项目论文

Endocrine practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy

Endocrine practice

相似文献

同项目论文

Endocrine practice

相关期刊

检索历史清除